Vaccines, Blood & Biologics
3/10/2008 Telecon - Rotarix
MEMORANDUM
| DATE: | March 10, 2008, 11:00 AM |
| FROM: | Laraine S. Henchal, Microbiologist Reveiwer, DVRPA, CBER, Review Committee Chair, STN 125265/0 |
| SUBJECT: | Telecon in regard to inclusion/exclusion of Neisseria meningitidis assay data from review for BLA for Rotarix® |
I received a call from Milan Blake and Chris Lynch in regard to the necessity for inclusion of Chris's review of the Neisseria meningitidis assay data in the BLA. Since the co-administration of other vaccines study 060 is considered by CBER to be the pivotal co-administration study, and no Neisseria vaccine was administered in that study, we all agreed that it was not necessary to include the assay review in the file.
CBER participants:
Laraine Henchal
Christian Lynch
Milan Blake
Contact Us
Consumer Affairs Branch (CBER)
- (800) 835-4709
- (301) 827-1800
- ocod@fda.hhs.gov
Division of Communication and Consumer Affairs
Office of Communication, Outreach and Development
Food and Drug Administration
1401 Rockville Pike
Suite 200N/HFM-47
Rockville, MD 20852-1448

